Non-alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Report

Non-alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Analysis Report By Type (Serum, Hepatic Fibrosis, Apoptosis, Oxidative Stress), By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs), And Segment Forecasts, 2018 - 2025

  • Published Date: Jul 2017
  • Report ID: GVR-1-68038-518-2
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016

Table of Contents

Chapter 1 Research Methodology
                 1.1 Country-wise market: Base estimates
                 1.2 Global market: CAGR calculation
                 1.3 Region based segment share calculation
                 1.4 Research Scope & Assumptions
                 1.5 List of Data Sources
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 NASH Biomarkers Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                 3.2 Market Driver Analysis
                     3.2.1 Increasing prevalence of chronic diseases
                     3.2.2 Increasing demand for non-invasive diagnostics for NASH biomarkers
                     3.2.3 Rising investment by government and private organizations in R&D for NASH biomarkers therapeutics
                 3.3 Market Restraint Analysis
                     3.3.1 Side-effects and risks associated with NASH therapeutics
                 3.4 Penetration & Growth Prospect Mapping
                 3.5 NASH biomarkers- SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.6 Industry Analysis - Porter’s
Chapter 4 NASH Biomarkers Market: Type Estimates & Trend Analysis
                 4.1 NASH Biomarkers Market: Type Movement Analysis
                 4.2 Serum Biomarkers
                     4.2.1 Serum biomarker market, 2014 - 2025 (USD Million)
                 4.3 Hepatic Fibrosis Biomarkers
                     4.3.1 Hepatic fibrosis biomarkers market, 2014 - 2025 (USD Million)
                 4.4 Apoptosis Biomarkers
                     4.4.1 Apoptosis biomarkers market, 2014 - 2025 (USD Million)
                 4.5 Oxidative Stress Biomarkers
                     4.5.1 Oxidative stress biomarkers market, 2014 - 2025 (USD Million)
                 4.6 Others
                     4.6.1 Others market, 2014 - 2025 (USD Million)
Chapter 5 NASH Biomarkers Market: End-use Estimates & Trend Analysis
                 5.1 NASH biomarkersMarket: End-use Movement Analysis
                 5.2 Pharma & CRO Industry
                     5.2.1 Pharma & CRO industry market, 2014 - 2025 (USD Million)
                 5.3 Hospitals
                     5.3.1 Hospitalsmarket, 2014 - 2025 (USD Million)
                 5.4 Diagnostic Labs
                     5.4.1 Diagnostic Labs market, 2014 - 2025 (USD Million)
                 5.5 Academic Research Institutes
                     5.5.1 Academic research institutes Market, 2014 - 2025 (USD Million)
Chapter 6 NASH biomarkers Market: Regional Estimates & Trend Analysis, by Type, and End-use
                 6.1 NASH biomarkers market Share by Region, 2016 & 2025
                 6.2 North America
                     6.2.1 North America NASH biomarkers market, by country, 2014 - 2025 (USD Million)
                     6.2.2 North America NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                     6.2.3 North America NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.2.4 U.S.
                         6.2.4.1 U.S. NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.2.4.2 U.S. NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.2.5 Canada
                         6.2.5.1 Canada NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.2.5.2 Canada NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                 6.3 Europe
                     6.3.1 Europe NASH biomarkers market, by country, 2014 - 2025 (USD Million)
                     6.3.2 Europe NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                     6.3.3 Europe NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.3.4 Germany
                         6.3.4.1 Germany NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.3.4.2 Germany NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.3.5 UK
                         6.3.5.1 UK NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.3.5.2 UK NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                 6.4 Asia Pacific
                     6.4.1 Asia PacificNASH biomarkers market, by country, 2014 - 2025 (USD Million)
                     6.4.2 Asia Pacific NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                     6.4.3 Asia Pacific NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.4.4 Japan
                         6.4.4.1 Japan NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.4.4.2 Japan NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.4.5 China
                         6.4.5.1 China NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.4.5.2 China NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.4.6 India
                         6.4.6.1 India NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.4.6.2 India NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                 6.5 Latin America
                     6.5.1 Latin America NASH biomarkers market, by country, 2014 - 2025 (USD Million)
                     6.5.2 Latin America NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                     6.5.3 Latin America NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.5.4 Brazil
                         6.5.4.1 Brazil NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.5.4.2 Brazil NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.5.5 Mexico
                         6.5.5.1 Mexico NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.5.5.2 Mexico NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                 6.6 MEA
                     6.6.1 MEA NASH biomarkers market, by country, 2014 - 2025 (USD Million)
                     6.6.2 MEA NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                     6.6.3 MEA NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
                     6.6.4 South Africa
                         6.6.4.1 South Africa NASH biomarkers market, by type, 2014 - 2025 (USD Million)
                         6.6.4.2 South Africa NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                 7.1 Strategy Framework
                 7.2 Market Participation
                 7.3 Company Profiles
                     7.3.1 GENFIT SA
                         7.3.1.1 Company overview
                         7.3.1.2 Financial performance
                         7.3.1.3 Products benchmarking
                         7.3.1.4 Geographic footprint
                         7.3.1.5 Strategic initiatives
                     7.3.2 Gilead Sciences, Inc. (GILD)
                         7.3.2.1 Company overview
                         7.3.2.2 Financial performance
                         7.3.2.3 Products benchmarking
                         7.3.2.4 Geographic footprint
                         7.3.2.5 Strategic initiatives
                     7.3.3 AstraZeneca
                         7.3.3.1 Company overview
                         7.3.3.2 Financial performance
                         7.3.3.3 Products benchmarking
                         7.3.3.4 Geographic footprint
                         7.3.3.5 Strategic initiatives
                     7.3.4 Novartis AG
                         7.3.4.1 Company overview
                         7.3.4.2 Financial performance
                         7.3.4.3 Products benchmarking
                         7.3.4.4 Geographic footprint
                         7.3.4.5 Strategic initiatives
                     7.3.5 Bristol-Myers Squibb Company
                         7.3.5.1 Company overview
                         7.3.5.2 Financial performance
                         7.3.5.3 Products benchmarking
                         7.3.5.4 Geographic footprint
                         7.3.5.5 Strategic initiatives
                     7.3.6 Allergan Plc
                         7.3.6.1 Company overview
                         7.3.6.2 Financial performance
                         7.3.6.3 Products benchmarking
                         7.3.6.4 Geographic footprint
                         7.3.6.5 Strategic initiatives
                     7.3.7 Novo Nordisk A/S
                         7.3.7.1 Company overview
                         7.3.7.2 Financial performance
                         7.3.7.3 Products benchmarking
                         7.3.7.4 Geographic footprint
                         7.3.7.5 Strategic initiatives
                     7.3.8 Boehringer Ingelheim
                         7.3.8.1 Company overview
                         7.3.8.2 Financial performance
                         7.3.8.3 Products benchmarking
                         7.3.8.4 Geographic footprint
                         7.3.8.5 Strategic initiatives
                     7.3.9 Pfizer Inc
                         7.3.9.1 Company overview
                         7.3.9.2 Financial performance
                         7.3.9.3 Products benchmarking
                         7.3.9.4 Geographic footprint
                         7.3.9.5 Strategic initiatives


List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 North America NASH biomarkers market, by country, 2014 - 2025 (USD Million)
TABLE 3 North America NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 4 North America NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 5 U.S. NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 6 U.S. NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 7 Canada NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 8 Canada NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 9 Europe NASH biomarkers market, by country, 2014 - 2025 (USD Million)
TABLE 10 Europe NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 11 Europe NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 12 Germany NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 13 Germany NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 14 UK NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 15 UK NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 16 Asia Pacific NASH biomarkers market, by country, 2014 - 2025 (USD Million)
TABLE 17 Asia Pacific NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 18 Asia Pacific NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 19 JapanNASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 20 JapanNASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 21 China NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 22 China NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 23 India NASH biomarkers market, by Type, 2014 - 2025 (USD Million)
TABLE 24 India NASH biomarkers market, by End-use, 2014 - 2025 (USD Million)
TABLE 25 Latin America NASH biomarkers market, by country, 2014 - 2025 (USD Million)
TABLE 26 Latin AmericaNASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 27 Latin AmericaNASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 28 Brazil NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 29 Brazil NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 30 Mexico NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 31 Mexico NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 32 MEA NASH biomarkers market, by country, 2014 - 2025 (USD Million)
TABLE 33 MEA NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 34 MEA NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)
TABLE 35 South Africa NASH biomarkers market, by type, 2014 - 2025 (USD Million)
TABLE 36 South Africa NASH biomarkers market, by end-use, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & Growth Prospect Mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 NASH biomarkers market, Type outlook: Key takeaways
FIG. 10 NASH biomarkers market: Type movement analysis
FIG. 11 Serum biomarkers market, 2014 - 2025 (USD Million)
FIG. 12 Hepatic fibrosis biomarkers market, 2014 - 2025 (USD Million)
FIG. 13 Apoptosis biomarkers market, 2014 - 2025 (USD Million)
FIG. 14 Oxidative stress biomarkers market, 2014 - 2025 (USD Million)
FIG. 15 Others market, 2014 - 2025 (USD Million)
FIG. 16 NASH biomarkers market, End-use outlook: Key takeaways
FIG. 17 NASH biomarkers market: End-use movement analysis
FIG. 18 Pharma & CRO industry market, 2014 - 2025 (USD Million)
FIG. 19 Hospitals market, 2014 - 2025 (USD Million)
FIG. 20 Diagnostic Labs market, 2014 - 2025 (USD Million)
FIG. 21 Academic research institutes market, 2014 - 2025 (USD Million)
FIG. 22 Regional market place: Key takeaways
FIG. 23 Regional outlook, 2016& 2025
FIG. 24 Strategy framework
FIG. 25 Market participation and categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.